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Background: Individuals with Anorexia Nervosa (AN) are renowned for their poor short- and long-term treatment
outcomes. To gain more insight into the reasons for these poor outcomes, the present study compared patients with
AN-R (restrictive subtype), AN-BP (binge-purge subtype), bulimia nervosa (BN), and eating disorder not otherwise
specified (EDNOS) over 12 weeks of specialized eating disorders treatment.
Eighty-nine patients completed the Eating Disorder Examination- Questionnaire (EDE-Q) and various measures of
psychosocial functioning at baseline, and again after weeks 3, 6, 9, and 12 of treatment.
Results: Multilevel modeling revealed that, over the 12 weeks, patients with AN-BP and AN-R had slower improvements
in global eating disorder pathology, shape concerns, and self-compassion than those with EDNOS and BN. Patients with
AN-BP had slower improvements in shame, social safeness (i.e., feelings of warmth in one’s relationships), and received
social support compared to those with AN-R, BN, and EDNOS.
Conclusions: These findings support the need for more effective and comprehensive clinical interventions for patients
with AN and especially AN-BP. Results also highlight not-yet studied processes that might contribute to the poor
outcomes AN patients often face during and after treatment.
Keywords: Anorexia nervosa, Transdiagnostic, Treatment process, Treatment outcome, Change trajectories,
Self-compassion, Received social support, Shame, Social safenessBackground
Individuals with Anorexia Nervosa (AN) typically fare
worse than those with other eating disorders, and it is
unclear why [1-3]. Patients with AN are more likely to
drop out of treatment prematurely and less likely to ex-
perience sustained symptom remission following treat-
ment [4-9]. They also face a risk of mortality that tends
to be higher than that of other psychiatric groups
[10-12]. Although it is known that AN is a persistent
and destructive illness, we know little about why long-
term outcomes are poorer for this eating disorder than
for others.
In an attempt to understand the dismal outcomes
associated with AN, many researchers have sought to
identify prognostic factors within AN-only samples. With
regards to pre-treatment predictors, certain characteristics
of the disorder, such as binge-purge behaviours and a* Correspondence: allison.kelly@uwaterloo.ca
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article, unless otherwise stated.lower BMI, and various psychosocial variables, such as
perfectionism, obsessive-compulsive traits, and socially
inhibited interpersonal patterns, have emerged as predic-
tors of poorer outcome over time [13-20]. Certain
discharge variables have also predicted long-term out-
come in AN. Relapse appears more likely among patients
who leave treatment with a greater drive to exercise, re-
sidual concerns about weight and shape, and a lower
readiness to maintain treatment gains [20,21]. Alcohol
abuse and poor social adjustment at discharge have also
predicted elevated mortality risk at long-term follow-up
[12]. Pre-treatment and post-treatment patient factors
therefore seem to be important predictors of long-term
outcomes in AN.
Next research steps
Although the field has identified numerous pre- and
post-treatment predictors of outcome among individuals
with AN, there are two gaps in the literature which, if
addressed, might help to explain why AN patients fare
worse than those with other eating disorders. First, theretral Ltd. This is an Open Access article distributed under the terms of the
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AN patients during treatment [16,22,23]. Most treatment
studies assess patients at two discrete time points (i.e.,
pre and post). Associated analytic approaches typically
exclude patients for whom an observation is missing,
leaving a biased sample. In addition, linear change is as-
sumed, but never confirmed. We therefore suggest that
it is important to assess patients’ functioning at various
time points over the course of treatment to allow for
analytical approaches that can more precisely model pat-
terns of change. Identifying the ways in which symptoms
and psychosocial functioning change – or remain the
same – during treatment might shed light on the poor
long-term outcomes AN patients face.
Second, there is little research on the ways in which
eating disorder diagnostic groups differ in their experi-
ences over the course of eating disorders treatment. This
relative absence of research may stem from practical is-
sues that make between-group comparisons difficult
during treatment. First, patients with severe AN often
attend different treatment programs from those with
other eating disorder patients. Second, weight restor-
ation is generally the most studied outcome variable in
AN, but is often not a relevant indicator of progress in
other eating disorder groups. We suggest value in de-
signing studies that overcome these barriers and render
comparisons between diagnostic groups possible. Such
studies may shed light on how individuals with AN differ
from those with other eating disorders, not only at the
start and end of treatment, but also as treatment
unfolds.
The present study
We sought to address the aforementioned gaps in the
literature on AN by comparing the change processes of
patients with AN-R, AN-BP, BN, and EDNOS during
specialized eating disorders treatment. We believed such
an approach would help us glean important information
about the factors we may be failing to adequately assess
and target during treatment. Given the prognostic rele-
vance of eating disorder symptoms and psychosocial fac-
tors in predicting long-term outcomes, we sought to
compare the trajectories of eating disorder subtypes in
both domains. We therefore administered multiple re-
peated measures of variables that have transdiagnostic
relevance to eating disorder patients, rendering between-
group comparisons possible. We assessed eating disorder
symptoms with the Eating Disorders Examination
Questionnaire (EDE-Q) and assessed psychosocial func-
tioning with measures of shame, social safeness, received
social support, and self-compassion.
Gilbert’s transdiagnostic theory of psychopathology
[24,25] inspired our selection of psychosocial variables.
Shame is a painful self-conscious feeling that derivesfrom seeing oneself as defective and imagining others
share this view. Gilbert proposed that shame contributes
to the maintenance of self-destructive behaviours seen in
many forms of psychopathology including eating disor-
ders. Feelings of social safeness, however, are considered
antidotal to shame. Social safeness is an emotional sense
of warmth, belonging, and calmness, and is thought to
arise from the soothing system in the brain, which is
sensitive to signals of compassion from others and self
[26,27]. According to Gilbert, the soothing system is
paramount to sustained well-being because it evolved to
tone down the threat system, which is highly implicated
in shame and psychopathology [28,29]. Gilbert proposed
that receiving compassion from others and/or self is the
optimal ways to stimulate the soothing system. There-
fore, we additionally examined received social support,
as an indicator of compassion received from others, and
self-compassion, defined as a kind, caring attitude to-
ward personal distress and shortcomings [30].
We hypothesized that, compared to patients with BN
and EDNOS, those with AN would have slower im-
provements over time in eating disorder pathology,
shame, social safeness, received social support, and self-
compassion. Given past research documenting the poor
prognoses associated with AN-BP, we expected that
these slower rates of improvement in AN would be espe-
cially pronounced among those with the AN-BP subtype
of the illness.
Methods
Sample
Participants were 89 patients admitted to the Toronto
General Hospital’s adult eating disorders program be-
tween September 2010 and August 2012. To be admitted
into either program, individuals must meet DSM-IV-TR
criteria for an eating disorder based on the Eating
Disorder Examination [31]. Exclusion criteria for treat-
ment included a diagnosis of binge eating disorder, hav-
ing an active substance-related disorder, being younger
than 18, and being unwilling to comply with the treat-
ment norms. Please see Figure 1 for a flow chart of the
recruitment process. The majority (72.2%) of partici-
pants was admitted to the eating disorder program’s day
hospital, and 27.8% was admitted to the program’s in-
patient unit.
Enough information was collected during intake as-
sessments to classify patients based on revised DSM-5
criteria. We therefore present the DSM-5 diagnostic
breakdown of our sample, but for simplicity, we group
those with specified and unspecified eating disorders
under EDNOS. Twenty-six (29.2%) participants had AN-
R, 17 (19.1%) had AN-BP, 26 (29.2%) had BN, and 20
(22.5%) had EDNOS. BMI at admission differed by diag-
nostic group; means were 15.8 (SD = 1.97) for AN-R,
Patients admitted to treatment program 
(n=192)
Did not agree to be contacted about study
(n = 57)
Agreed to be contacted about study
(n=135)
Did not return research team’s phone calls 
(n=27)
Met with research assistant to review 
study objectives and procedures
(n=108)
Diagnosis information not available, 
therefore excluded from analyses
(n=8)
Included in final analyses 
(n=87)
Did notconsent to participate 
(n=11)
Consented to participate
(n=97)
Figure 1 Recruitment and participation flow-chart.
Kelly and Carter Journal of Eating Disorders 2014, 2:2 Page 3 of 10
http://www.jeatdisord.com/content/2/1/217.08 (SD = 1.54) for AN-BP, 24.52 (SD = 6) for BN, and
23.02 (SD = 4.15) for EDNOS. Of those with EDNOS,
three had subthreshold AN-R, four had subthreshold
AN-BP, five had subthreshold BN, four had purging dis-
order, and four had unspecified eating disorders. Eight of
those with EDNOS had BMIs between 18 and 20, and
the remaining 12 had BMIs of 20 and above. The mean
number of previous admissions into the treatment pro-
gram was 1.29 (SD = .77) and this number did not differ
by diagnostic group.
Our sample was predominantly female (97%) and the
ethnic breakdown was 79.2% Caucasian, 4.5% East
Asian, 1.4% South Asian, 2.8% African-Canadian, 10.8%
Latino, and 1.5% mixed race. Participants’ mean age was
28 years (SD = 9.6); a minority of patients (17.4%) was
between 17 and 19 years of age and the remainder
was 20 and older. The diagnostic groups did not differ
in any of our demographic variables.
Treatment programs
The day hospital and inpatient eating disorders pro-
grams at the Toronto General Hospital are run bymultidisciplinary teams, consisting of psychiatrists, psy-
chologists, nurses, dieticians, social workers, and occu-
pational therapists. Treatment consists of group therapy
as well as staff-supported meals and snacks. The program
focuses on medical stabilization, nutritional rehabilitation
and normalized eating, eradication of symptomatic behav-
iours, and in the case of underweight patients, weight res-
toration [32]. Patients are admitted to these programs on
an ongoing basis whenever a spot becomes available. As
such, group make-up fluctuates over time. The duration of
treatment also varies by patient. Those admitted to the day
hospital commit to eight weeks of intensive treatment, and
then go onto a less intensive version of treatment. Those
admitted to the inpatient unit remain in the program until
they have reached a BMI of 20, and then move into the
day hospital for eight weeks. Unless patients choose to
leave treatment prematurely or are asked to leave because
of non-compliance, patients across programs remain in
some version of treatment for at least 12 weeks.
Procedure
Ethics approval was obtained from the University Health
Network Research Ethics Board. Participants were asked
to complete online questionnaires at the start of their
admission, and again after three, six, nine, and 12 weeks
of treatment. Questionnaires were emailed to them in
the form of a web link, and participants were asked to
try and complete them within 48 hours of receiving
them. On average, participants completed assessments
4.3 (SD = 1.1) weeks apart from one another.
Measures
Eating disorder symptoms
The 36-item Eating Disorder Examination–Question-
naire (EDE-Q) was used to assess eating disorder symp-
toms over the previous 28 days [33]. Although
questionnaires in this study were administered every
21 days, the fact that the average participant completed
surveys late (ever 4.3 weeks) made the assessment win-
dows consistent with the EDE-Q time frame. The EDE-
Q generates scores from 0 to 6 on four subscales of
Shape Concern, Weight Concern, Eating Concern, and
Dietary Restraint. These subscales represent transdiag-
nostic eating disorder symptoms. A global score of eat-
ing disorder pathology is calculated by taking the mean
of these four subscale scores. The EDE-Q’s test-retest
reliability and internal consistency are strong [34]. In
the present sample, Cronbach alphas were .96 for the
global score, .89 for Shape Concern, .81 for Weight
Concern, .88 for Eating Concern, and .83 for Dietary
Restraint. Participants had a mean EDE-Q global
score of 4.04 (SD = 1.32) at the time of their admis-
sion, confirming their clinically severe eating disorder
pathology [35].
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Shame was assessed using the 25-item Experience of
Shame Scale (ESS) [36]. The ESS generates global shame
score, computed by taking the mean of all items, as well
as subscale scores representing body shame, character
shame, and behaviour shame. A factor analysis of all ESS
items in our sample supported a one-factor solution.
Sample items from the ESS, rated from 1 (not at all) to 4
(very much) include: “Have you felt ashamed of the sort
of person you are?” and “Have you tried to cover up or
conceal things you felt ashamed of having done?” The
ESS has evidence of high test-retest reliability, good dis-
criminant and construct validity, and high internal
consistency, the latter of which was reflected by a Cron-
bach’s alpha of .95 in our sample. Participants had a
mean global shame score of 3.15 (SD = .65) at the time
of their admission.
Social safeness
We assessed social safeness with the Social Safeness and
Pleasure Scale (SSPS) [26]. This 11-item measure uses a
0–4 scale to ask participants to rate the extent to which
they experience a sense of warmth, reassurance, and be-
longing in their social relationships. Sample items in-
clude: “I feel easily soothed by those around me,” I feel
connected to others,” and “I feel a sense of warmth in
my relationships with people.” This measure has been
found to have strong internal consistency, which was
demonstrated by a Cronbach’s alpha of .94 in our sam-
ple. Mean social safeness at baseline was 1.4 (SD = .95).
Received social support
We measured received social support (RSS) with the
Social Provisions Scale (SPS-short) [37]. The SPS-short
is a 6-item measure that can be used to assess percep-
tions that social support would be available if needed
(perceived social support), as well as actual social support
received (RSS). We administered the RSS version only.
Using a 7-point Likert scale, participants rated the extent
to which they received each of six social provisions over
the previous three weeks: guidance, assistance, emotional
closeness, social integration, reassurance of worth, and
opportunity for nurturance. Sample items include: “To
what extent did another person(s) come to your assist-
ance,” and “To what extent did another person(s) provide
you with a sense of emotional security and well-being.”
The scale’s Cronbach’s alpha was .80, demonstrating
adequate internal consistency. Participants’ mean baseline
score was 4.6 (SD = 1.36).
Self-compassion
The 12-item Self-Compassion Scale-Short Form (SCS-
SF) was used to assess self-compassion [38]. The SCS-SF
asks participants to use a 5-point scale to rate theirtypical reactions at times of personal distress. Sample
items include “I try to be kind and patient towards those
aspects of my personality I don’t like,” “I try to see my
failings as part of the human condition,” and “When
something painful happens I try to take a balanced view
of the situation.” This shortened version of the Self-
Compassion Scale correlates near perfectly with the full,
26-item version [30]. In the current study, the SCS-SF
had a Cronbach’s alpha of .85, demonstrating good in-
ternal consistency. Participants’ mean self-compassion
score at baseline was 2.04 (SD = .68).
Patterns of missing data
At baseline (Time 0), participants completed all ques-
tionnaires through a study-specific survey with the ex-
ception of the EDE-Q, which was administered as part
of the clinical intake process. Time 0 responses on the
EDE-Q were available for 80 of the 89 participants; eight
patients did not complete their questionnaire, and six
patients left treatment before returning their responses.
Responses for all other study measures (e.g., shame, self-
compassion) at Time 0 were available for all 89 partici-
pants. On average, participants completed 3.65 out of 5
assessments over the 12 study weeks, with 58 of the 89
participants completing three or more questionnaires.
Analytic strategy
Our primary analytic approach was multilevel modeling
with maximum likelihood estimation. This is the recom-
mended statistical approach when modeling participant
trajectories over time [39]. Two notable advantages of
multilevel modeling in longitudinal studies are its ability
to model change trajectories without fixed data collec-
tion schedules, and its ability to retain data from partici-
pants for whom observations are missing at random
(MAR). MAR means that the observations that are miss-
ing are unrelated to the unobserved value(s) but may be
related to the unobserved value(s) through other vari-
ables in the model for which observations are not miss-
ing [40]. We found evidence to support the MAR
assumption in the present data set.
We tested our hypotheses using PROC MIXED in SAS
9.3. Dependent variables were EDE-Q eating disorder
symptoms, shame, social safeness, received social sup-
port, and self-compassion across all available time points
between weeks 0 and 12 of treatment inclusive. Because
participants commonly completed surveys later than
they were asked, we used time stamps to enter the pre-
cise time point in their treatment course (i.e., 3 weeks,
4.5 weeks, etc.) at which they completed each of their
surveys for greater precision [41].
All multilevel models contained a fixed and random
effects portion, and an unstructured error covariance.
We included a random effect for intercept and time.
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EDNOS), Diagnosis x Time, baseline levels of the out-
come variable (covariate), and the former’s interaction
with time. Demographic variables (e.g., age, marital sta-
tus, living circumstances), treatment program (i.e., in-
patient vs. day hospital), BMI, and their interactions
with time were initially included as fixed effects, but
these terms were dropped from final models because
none was significant.
Preliminary analyses revealed that baseline EDE-Q glo-
bal and subscale scores varied by diagnostic group;
therefore, we sought to control for shared variance be-
tween eating disorder pathology and diagnosis in our
models. We therefore included the relevant baseline
EDE-Q score and its interaction with time as fixed ef-
fects in our models. In all models, a significant effect for
Diagnosis x Time would indicate that the dependent var-
iables changed over a time as a function of participants’
eating disorder diagnosis. We then probed significant
Diagnosis x Time interactions with simple slope esti-
mates, representing rates of change, for each diagnostic
group. Contrasts were then used to compare rates of
change across AN-R, AN-BP, EDNOS, and BN. In
addition, mean point estimates of the dependent variable
were calculated and plotted for each diagnostic group at
weeks 0, 3, 6, 9, and 12.
Results
Preliminary analyses
First, Pearson zero-order correlations were computed
between study variables at baseline to provide informa-
tion on the distinguishability of our dependent variables
from one another (see Table 1). Inter-correlations be-
tween EDE-Q subscales indicate that these variables
shared anywhere from 46% to 69% of their variance,
whereas the EDE-Q subscales shared anywhere from
74% to 83% of their variance with the EDE-Q global
scale. No other pair of variables shared more than halfTable 1 Zero-order correlations between study variables at b
EDE-Q Global EDE-Q Restraint EDE-Q Weight EDE-Q
EDE-Q global – .86a*** .91a*** .91
EDE-Q restraint – .68 a*** .69
EDE-Q weight – .83
EDE-Q shape
EDE-Q eating
Shame
Social safeness
Self-compassion
RSS
an = 89; bn = 87; cn = 76; dn = 75.
Note. EDE-Q, eating disorders examination questionnaire. RSS, received social suppo
*p < .05; ***p < .001.of their variance indicating that the psychosocial vari-
ables are related to one another, and to eating disorder
pathology, but are distinguishable constructs.
Second, a series of multiple regressions was con-
ducted, using PROC GLM in SAS, to determine whether
the four diagnostic groups differed on any of our study
variables at baseline. We found that diagnosis predicted
baseline EDE-Q global scores, F (3, 76) = 2.93, p < .05,
eating concerns, F (3, 76) = 3.48, p < .05, weight con-
cerns, F (3, 76) = 2.78, p < .05, and shape concerns, F (3,
76) 4.38, p < .01, but not restraint, F (3, 76) = 1.0, n.s.
Contrasts revealed that individuals with AN-R reported
lower total and subscale scores than the other groups,
p’s < .01. Controlling for baseline EDE-Q Global, diagno-
sis also emerged as a significant predictor of baseline so-
cial safeness, F (3, 74) = 3.32, p < .01. Contrasts revealed
that on average, the AN-R and AN-BP groups reported
feeling less socially safe at baseline than the EDNOS and
BN groups, F (1, 76) = 8.61, p < .01. There was no effect
of diagnosis on baseline received social support, shame,
or self-compassion, indicating that patients across the
four diagnostic groups did not differ from one another
in these variables at the start of the study.
Does diagnosis predict rate of change in outcome
variables?
Eating disorder symptoms
We first examined EDE-Q Global scores as the
dependent variable. A significant effect was found for
Diagnosis x Time, F (3, 214) = 2.66, p < .05. Simple slope
estimates revealed that all diagnostic groups had signifi-
cant decreases in EDE-Q global pathology over time,
p’s < .001. Simple slope estimates for each diagnostic
group are presented in Table 2. Planned contrasts re-
vealed that on average, individuals with AN-R and AN-BP
had slower EDE-Q Global decreases over time than those
with EDNOS and BN, F (1, 214) = 7.81, p < .01. Mean
point estimates in EDE-Q Global scores were calculatedaseline
Shape EDE-Q Eating Shame Safeness Self-Compassion RSS
a*** .90 a*** .67b*** -.49c*** -.45b*** -.26c*
a*** .71a*** .52b*** -.40c*** -.29b* -.26c*
a *** .75a*** .60b*** -.40c*** -.43b*** -.24c*
– .76a*** .62b*** -.44c*** -.43b*** -.21c
– .64b*** -.49c*** -.47b *** -.22c
– -.62 c *** -.52d*** -.24c*
– .61 c *** .63 c***
– .34c***
–
rt.
Table 2 Estimated rates of change (Slopes) in dependent variables by diagnostic group
AN-R AN-BP BN EDNOS Planned Contrasts
EDE-Q Global −11 (.03) *** -.11 (.03) *** -.18 (.03) *** -.20 (.03) *** AN < BN & EDNOS *
EDE-Q Restraint -.22 (.03) *** -.16 (.03) *** -. 21 (.02) *** -.32 (.03) *** AN-BP < Others ***
EDE-Q Shape concern -.00 (.04) -.04 (.04) -. 16 (.04) *** -.15 (.04) *** AN < BN & EDNOS ***
Shame -.05 (.02) ** -.01 (.02) -.07 (.02) *** -.10 (.02) *** AN-BP < Others **
Social safeness .03 (.02) * -.01 (.02) .02 (.01) .07 (.02) * AN-BP < Others *
EDNOS > Others *
Received social support .00 (.04) -.06 (.03) * -.01 (.03) .08 (.03) * AN-BP < Others *
EDNOS > Others *
Self-compassion -.00 (.01) -.01 (.01) .05 (.01) *** .06 (.02) *** AN < BN & EDNOS ***
Note. EDE-Q, eating disorders examination questionnaire. The last column presents the results of planned contrasts between diagnostic groups for dependent
variables where Diagnosis x Time emerged as a significant predictor.
*p < .05; **p < .01; ***p < .001.
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and 12 (see Figure 2a).
We then examined each EDE-Q subscale separately
as a dependent variable. There was no Diagnosis x
Time effect when predicting Eating Concerns, F
(3, 214) = .74, n.s., or Weight Concerns, F (3, 214) =
1.38, n.s. Diagnosis x Time did, however, predict Re-
straint, F (3, 214) = 5.2, p < .01, and Shape Concerns,
F (3, 214) = 4.3, p < .01. With regards to Restraint,
simple slope estimates revealed that all diagnostic
groups showed significant decreases in dietary re-
straint over time, p’s < .001 (see Table 1). Contrasts
additionally revealed that the EDNOS group improved
at a faster rate than the average of the other three
diagnostic groups, F (1, 214) = 12.51, p < .001. Further-
more, the AN-BP group improved at a slower rate
than the average of the other three groups, F (1, 214) =
8.34, p < .01. Those with AN-R and BN were similar in
their improvements, F (1, 214) = .28, n.s.
With regards to shape concerns, simple slope esti-
mates revealed non-significant improvements over time
for those with AN-R and AN-BP and significant
decreases over time for those with BN and EDNOS,
p’s < .001 (see Table 2). Planned contrasts additionally re-
vealed that those with AN-R and AN-BP improved at a
significantly slower rate than those with EDNOS and
BN, F (1, 214) = 12.12, p < .001.
Shame
There was a significant effect of Diagnosis x Time pre-
dicting changes in shame, F (3, 185) = 4.03, p < .01. As
presented in Table 2, simple slope estimates revealed sig-
nificant decreases in shame over time in the AN-R, BN,
and EDNOS groups. The AN-BP group, however, did
not improve over time, and this trajectory differed sig-
nificantly from the average rate of change of the other
three diagnostic groups, F (1, 185) = 8.45, p < .01 (see
Figure 2b).Social safeness
A significant effect was found for Diagnosis x Time, F
(3, 181) = 2.63, p = .05 predicting changes in social safe-
ness. As seen in Table 2, simple slope estimates indi-
cated that the AN-R and EDNOS groups had significant
increases in social safeness over time; the AN-BP and
BN groups, however, reported no changes in social safe-
ness over time. Planned contrasts revealed that the tra-
jectory of the AN-BP group had a significantly slower
change trajectory from the average of the other three
diagnostic groups, F (1,181) = 5.47, p < .05. In addition,
the EDNOS group had a significantly faster change tra-
jectory than the average of the other three groups, F
(1,181) = 5.24, p < .05 (see Figure 2c).
Received social support
We found a significant effect for Diagnosis x Time pre-
dicting changes in received social support, F (3, 181) =
2.94, p < .05. Simple slope estimates, presented in Table 2,
revealed that the AN-R and BN groups had no changes
in received social support over time. The AN-BP group,
however, had significant decreases in in received support
over time, and the EDNOS group had significant in-
creases over time. Once again, the AN-BP group differed
significantly in its trajectory compared to the average
trajectory shown by the AN-R, BN, and EDNOS groups,
F (1,181) = 6.02, p < .05. The EDNOS group also differed
significantly, showing a faster rate of change than the
average of the other three diagnostic groups, F (1,181) =
6.28, p < .05. Figure 2d displays a graphic representation.
Self-compassion
Diagnosis x Time predicted changes in self-compassion,
F (3, 183) = 5.71, p < .001. Simple slope estimates, seen
in Table 2, indicated non-significant improvements over
time for the AN-R and AN-BP diagnostic groups. The
BN and EDNOS groups, however, showed significant in-
creases in self-compassion over time. The average rate
Figure 2 Diagnosis x time predicting changes in eating disorder symptoms and psychosocial functioning. Displays estimated means and
standard error bars for a) EDE-Q global, b) shame, c) social safeness, d) received social support, and e) self-compassion at baseline, week 3, week
6, week 9, and week 12 for each diagnostic group.
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nificantly greater than the average of the AN-R and AN-
BP groups, F (1, 183) = 16.45, p < .001. See Figure 2e for
a graphic representation.
Summary
As presented in Table 2, individuals with AN-BP had
slower improvements in dietary restraint, shame, social
safeness, and received support compared to those with
AN-R, EDNOS, and BN. Individuals with AN-BP and
AN-R had comparable trajectories in global eating dis-
order pathology, shape concerns, and self-compassion,
and these rates of change were poorer than those experi-
enced by patients with EDNOS and BN.
Discussion
This was the first study to our knowledge to compare
eating disorder diagnostic groups’ trajectories of change
over multiple time points during treatment. Of note,
changes in all outcome variables occurred in a linear
manner. We found that compared to patients with BN
and EDNOS, patients with AN, and especially those with
AN-BP, had the slowest improvements in eating disorder
symptoms and psychosocial functioning over 12 weeks
of treatment. Both the AN-BP and AN-R groups had
slower improvements in global eating disorder path-
ology, shape concerns, and self-compassion over time
compared to those with BN and EDNOS. The AN-BP
group had slower and generally non-significant improve-
ments in dietary restraint, shame, social safeness, and re-
ceived social support compared to those with AN-R, BN,and EDNOS. These results suggest previously unknown
ways in which patients with AN, and particularly AN-BP,
fare worse than other eating disorders patients over the
course of specialized treatment.
Eating disorder pathology
Using the EDE-Q as a transdiagnostic indicator of eating
disorder pathology, we found that patients with AN-BP
had the slowest improvements in dietary restraint over
12 weeks of treatment. In addition, both AN-BP and
AN-R patients had the slowest improvements in global
eating disorder pathology and shape concerns. The fact
that AN patients generally improved more slowly than
other eating disorder patients is perhaps not surprising
given what is known about the recalcitrant nature of
AN. It is noteworthy, though, that although AN patients
had slower improvements in shape concerns over treat-
ment, there was no effect of diagnosis on changes in
weight concerns or eating concerns over 12 weeks, sug-
gesting that patients with AN-R and AN-BP only differ
from those with BN and EDNOS in their rates of
improvement on certain aspects of eating disorder path-
ology. It is nevertheless important to note that the EDE-Q
subscales correlated fairly highly with one another, and
with the EDE-Q global score, making it important to repli-
cate this finding in future research.
Shame and social safeness
Over 12 weeks of treatment, individuals with AN-R, BN,
and EDNOS experienced significant increases in social
safeness and decreases in shame. Individuals with AN-
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these areas, and their trajectories differed from the aver-
age trajectory of the other three groups. These findings
suggest that compared to their fellow patients, AN-BP
sufferers experienced a more persistent sense of isolation
and defectiveness over the course of treatment, with no
improvement in feelings of inadequacy and faultiness, or
in feelings of social connectedness, warmth, and belong-
ingness. The lack of improvement in shame that AN-BP
patients tend to show is particularly concerning in light
of growing research documenting the maintaining role
that shame plays in the eating disorders [42-44]. Find-
ings are also noteworthy given the group-based nature
of our treatment programs, where staff and co-patients
are encouraged to be supportive of another. Our results
suggest there may something unique about individuals
with AN-BP that limits the emotional benefits they are
able to derive from group-based therapy.
Received social support
Individuals with AN-BP reported significant decreases in
received social support over time, a trajectory that dif-
fered significantly from the average of the three other
diagnostic groups. EDNOS patients were the only group
to show improvements in received support over time,
and those with AN-R and BN reported no changes. Be-
cause received support was assessed through self-report,
it is difficult to know whether the decreases AN-BP pa-
tients reported were objective in nature, or whether they
primarily reflected patients’ emotional sense of insecur-
ity and isolation. The measure of received support also
does not allow us to determine whether patients
responded to items based on their experiences within
the treatment context, outside of treatment, or both. In
future research, it would be interesting to examine
whether certain interpersonal patterns characteristic of
AN-BP, such as being cold/distant, socially inhibited,
and vindictive/self-centered [19], may lead these patients
to lose favour among co-patients and therapists as treat-
ment progresses.
Self-compassion
Patients with AN-R and AN-BP had slower and non-
significant changes in self-compassion over 12 weeks
compared to patients with BN and EDNOS. This finding
suggests that whereas BN and EDNOS patients come to
relate to their distress with more kindness and patience
over the course of therapy, individuals with AN do not.
Rather, they report no improvements in their self-
compassion – that is, their tendency to respond to their
feelings of inadequacy with self-kindness rather than self-
judgment, mindfulness rather than over-identification,
and a perspective that suffering is common to humanity
rather than isolating. It would be interesting to knowwhether these persistently low levels of self-compassion
contribute to the poorer outcomes AN patients tend to
experience during and after treatment for their eating dis-
order. Indeed, there is growing evidence that deficits in
self-compassion are associated with more severe and pro-
longed eating disorder pathology in eating disorder pa-
tients [45].
Limitations and future research
This study has a number of limitations. First, it was
correlational in nature meaning we must be cautious
about interpreting the results. Specifically, we cannot
conclude that patients’ eating disorder diagnosis
played a causal role in determining their change tra-
jectories. Second, the sample was quite heterogeneous
in nature, and treatment intensity varied across pa-
tients. Although these sample and treatment charac-
teristics were partly inevitable due to the nature of
our research question, it would be advisable to repli-
cate the present findings in a treatment setting where
patients across diagnostic groups undergo the same
intensity and duration of treatment. Indeed the
present results should be viewed as preliminary.
Third, there were no follow-up assessments of pa-
tients beyond the 12-week study. In future research,
it will be interesting to examine the ways in which
patients trajectories change or remain the same after
treatment. Fourth, although our sample size was rela-
tively large, it will be important to replicate our re-
sults in even larger transdiagnostic samples of eating
disorder patients.
Conclusions
The present study provides evidence that patients with
AN, and especially those with AN-BP, undergo processes
during treatment that differ from those with BN and
EDNOS. In particular, their symptoms and psychosocial
functioning improve at a slower pace, and often – par-
ticularly in the case of AN-BP – at a non-significant
pace. Previous research has found that within AN-only
samples, poorer psychosocial functioning and more se-
vere illness markers predicted worse outcomes. Our
findings extend this research by suggesting that it is not
just a subset of AN patients who warrant greater clinical
attention. Rather, the trajectories of change AN and es-
pecially AN-BP patients showed in our study suggest
that compared to patients with BN and EDNOS. Our
findings suggest that AN patients may require more
comprehensive interventions than those with other eat-
ing disorders. It might be important to investigate psy-
chotherapeutic approaches whose integration into
current treatments would allow clinicians to better tar-
get shame, social safeness, social support, and self-
compassion.
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